ABPI

Downing Street, London, UK
#ABPI #Antibiotic resistance #Antimicrobial resistance (AMR) #UK government

UK announces £210 million fund to tackle antimicrobial resistance

The UK government has announced up to £210 ($267) million of funding to partner with countries across Asia and Africa to tackle antimicrobial resistance (AMR) and reduce the threat posed to the UK. The announcement follows the £39 ($48) million investment through the Global… Read More

#News

Great British Pounds, Investment
#ABPI #BioIndustry Association #Biologics / Biotechnology #Clarivate #Financing #Investment #UK

UK biotech financing up 29% on last quarter

The second quarter of 2023 has seen steady growth in financing activity for the UK’s life sciences sector, according to new data released by the BioIndustry Association (BIA) and Clarivate. The positive news comes soon after industry figures welcomed recent announcements to unlock new sources of capital in the City… Read More

#Business & Investment #News

UK financial markets
#ABPI #Investment #Life sciences #UK #UK government

International investors abandon UK life sciences

International investors are abandoning UK life sciences as excessive revenue clawback rates start to bite, according to the latest Life Sciences Competitiveness Indicators published by the government1. The UK saw a substantial drop in the estimated value of inward life sciences foreign direct investment (FDI) in 2022 compared to 2021,… Read More

#Business & Investment #Editor's Choice #News

UK
#ABPI #Healthcare #NHS #The King's Fund #UK

UK performs poorly on adoption of new drugs, report shows

The UK spends less on medicines, has a lower adoption of new drugs and poorer health outcomes compared to other similar countries, according to a new report. The King’s Fund report, commissioned by the Association of the British Pharmaceutical Industry (ABPI), gives the UK’s NHS a… Read More

#News

#ABPI #AstraZeneca #Daiichi Sankyo #LEO Pharma #Prescription Medicines Code of Practice Authority (PMCPA) #Regulatory

Pharma watchdog calls out Leo, AZ and Daiichi Sankyo for misleading ads 

The Prescription Medicines Code of Practice Authority (PMCPA), a self-regulatory body which administers the Association of the British Pharmaceutical Industry (ABPI) Code of Practice for the Pharmaceutical Industry, have opened cases against Leo Pharma, AstraZeneca and Daiichi Sankyo for bringing discredit upon, and reducing confidence in, the pharmaceutical industry. AstraZeneca  … Read More

#News #Regulatory

Antibiotics
#ABPI #Antibiotics #Antimicrobial resistance (AMR) #Investment #UK government

UK government invests £39 million in AMR research

The UK government will invest up to £39 ($48) million in antimicrobial resistance (AMR) research through the Global AMR Innovation Fund (GAMRIF). The funding includes up to £25 ($30.9) million awarded to support the early development of new antibiotics, vaccines, rapid diagnostics and other products to… Read More

#Editor's Choice #News

Clinical trial
#ABPI #Clinical trial design #Clinical trials #MHRA #UK

Biggest overhaul of UK clinical trial regulation for 20 years

A series of new measures will be introduced by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) to make it faster and easier to gain approval and run clinical trials in the UK. These changes represent the biggest overhaul in UK clinical trials regulation in… Read More

#News

Novo Nordisk head office
#ABPI #Association of the British Pharmaceutical Industry #Novo Nordisk #Pharmaceutical industry #UK

Novo Nordisk suspended from UK’s ABPI membership

Novo Nordisk has been suspended as a member of the Association of the British Pharmaceutical Industry (ABPI) for two years due to serious breaches of the ABPI Code of Practice. This is the eighth occasion in the past 40 years the ABPI Board has issued such… Read More

#News

Pharmaceuticals manufacturing
#ABPI #Appointment #Association of the British Pharmaceutical Industry #New appointment #Pharmaceutical industry #UK

Susan Rienow confirmed as next President of the ABPI 

The ABPI Board has confirmed that Susan Rienow, UK Country President of Pfizer, will be the next President of the Association of the British Pharmaceutical Industry (ABPI).   Rienow was appointed as ABPI Vice-President in September 2022 and will formally take up her role as President in May… Read More

#News

Protesting against health inequalities
#ABPI #Collaboration #Drug discovery #Drug innovation #NHS #Pharma #UK

NHS/industry collaboration could improve access to drugs

Collaborative working between the NHS and industry could reduce variations in uptake of innovative treatments across the UK, a joint report from NHS Confederation and ABPI argues.   Analysis from the report has shown a significant variation in access to innovative medicines for patients across the UK and… Read More

#News

#AbbVie #ABPI #Clinical trials #Eli Lilly #Life sciences #Pharmaceutical industry #Pharmaceuticals #UK #UK government

Pharma firms pull out of UK drug pricing agreement

AbbVie and Eli Lilly have left the voluntary medicines pricing agreement in protest over what they describe as “increasingly punitive revenue clawbacks”.  The companies have left the UK’s Voluntary Scheme for Branded Medicines Pricing and Access (VPAS), a long-standing agreement between government and industry with roots going back to the… Read More

#Business & Investment #News #Trending News

Batch testing pharmaceuticals
#ABPI #Batch testing #EU #Pharmaceuticals #Testing #UK

UK clarifies post-BREXIT batch testing rules for pharmaceuticals 

The UK government has announced its future strategy for batch testing of medicinal products.  The new strategy means that the UK will continue to recognise batch testing from the EU/EEA, rather than insisting on duplicative batch testing operations.  Post-BREXIT, the pharmaceutical industry urged the UK… Read More

#News

World AMR Awareness Week logo
#ABPI #Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Association of the British Pharmaceutical Industry #UK

New antibiotics the only way to combat AMR, says ABPI 

Developing new antibiotics is essential to winning the fight against resistant infections, the Association of the British Pharmaceutical Industry (ABPI) has said.  The comments come ahead of World Antimicrobial Awareness Week (18-24 November), which aims to improve the awareness and understanding of antimicrobial resistance (AMR).   The… Read More

#News #Trending News